82%) inhibition, which was reproduced by preincubation of only the adherent cells in BBG. Preincubation of only the nonadherent cells in BBG was not inhibitory.
Inhibition (a) was independent of whether gangliosides were added in solution or incorporated into liposomes, (b) was abrogated by adding untreated monocytes to cultures containing adherent cells that were preexposed to BBG (excluding the possibility that BBG was inducing suppression mediated by adherent cells), and (c) was reversible by further incubation of BBG-pretreated adherent cells in control medium. Together, these results delineate a mechanism by which gangliosides modulate lymphoproliferative responses-direct, noncytotoxic, and ultimately reversible inhibition of the accessory function of adherent monocytes.
Introduction
Gangliosides are sialic acid-containing glycosphingolipids which, in the cell, are localized primarily on the membrane. Recent studies indicate that gangliosides synthesized by proliferating cells may be released into the local environment of the tumor and possibly into the peripheral circulation of tumor-bearing hosts in vivo (1) (2) (3) (4) . Coupled with the demonstration of potent inhibitory effects of gangliosides on cellular immune responses (4) (5) (6) (7) , these data stress the importance of understanding the mechanisms of ganglioside-induced inhibition, especially as it may relate to the suppressed cell-mediated immunity associated with certain disease states such as cancer.
To approach this question, we have considered possible explanations for the finding that soluble specific antigeninduced lymphoproliferative responses are quantitatively more susceptible to inhibition by gangliosides than are nonspecific mitogen-induced responses (4, 8) . Intact monocyte accessory function is an absolute requirement for soluble antigen-specific human lymphoproliferative responses (9, 10) . The present studies were thus performed to determine which subpopulation of human peripheral blood mononuclear cells (PBMC)' is susceptible to inhibition by preincubation with gangliosidesthe adherent cells (predominantly monocytes) or the nonadherent cells (enriched in T lymphocytes). Our results indicate that preincubation with gangliosides selectively paralyzes the accessory functional capability of adherent monocytes in a direct and ultimately reversible manner, but does not impair the subsequent responsiveness of nonadherent cells to antigenic stimulation.
Methods
Gangliosides. Mixed bovine brain gangliosides (BBG, catalog number 4-6037, lots LA-03608, -9460, -010135, Supelco, Inc., Bellefonte, PA) were further purified by removal of material insoluble in chloroform/ methanol 1:1 and by Sephadex G-50 gel filtration (4) . Gangliosides were quantitated as nanomoles lipid-bound sialic acid (LBSA) by the modified resorcinol colormetric assay (I 1). These extensively purified BBG contained <0.02 mol% protein (Markwell, M. A. K., unpublished results), quantitated as previously described (4), and were free of contaminating phospholipids and neutral glycolipids as assessed by thin-layer chromatography (4) .
For addition to the cell cultures, BBG were dissolved in sterile RPMI-1640 (Gibco, Grand Island, NY) and sonicated under N2 for 2 min at room temperature. In selected experiments, BBG were first incorporated into liposomes consisting of cholesterol/lecithin/BBG in a molar ratio of 1:1:1 by previously described procedures (7) . Neither BBG alone, cholesterol-lecithin liposomes, nor liposome-incorporated BBG were cytotoxic to PBMC or PBMC subpopulations as assessed by trypan blue dye exclusion at the end of either preincubation or culture periods.
Cells. PBMC were isolated by Ficoll-Hypaque density gradient centrifugation (12) from whole blood collected in preservative-free heparin (50 U/ml). These cells were washed three times and resuspended in complete medium that consisted of RPMI-1640 supplemented with glutamine (2 mM), penicillin (50 U/ml), streptomycin (50 sg/ml), and 10% autologous plasma. PBMC contained 25-30% monocytes, as assessed by nonspecific esterase staining of cytocentrifuge preparations (13).
Separation of PBMC subpopulations. To obtain the adherent cell subpopulation, 2 X l10 PBMC in 100 pl complete medium were added per well to 96 well flat-bottom microtiter plates (Flow Laboratories, McLean, VA) and incubated for 2 h at 37°C in humidified 95% air/ 5% CO2. After three washings to remove nonadherent cells, the wells contained -5 X 104 adherent cells (>95% esterase-positive and >99% viable by trypan blue dye exclusion). The nonadherent cell subpopulation was isolated by incubating 107 PBMC in 5 ml complete medium in 15 X 100-mm polystyrene petri dishes for 2 h at 370C in 95% air/ 5% CO2. The dishes were swirled gently and the nonadherent cell population recovered. After a second adherence, the resulting nonadherent cell population contained <2% monocytes.
Assessment oflymphoproliferative responses. Proliferative responses varying concentrations of BBG on lymphoproliferative responses to a nonspecific mitogen, PHA, and to a soluble specific antigen, tetanus toxoid, were compared. At each concentration of BBG tested, inhibition of the response to the specific antigen was significantly greater (P < 0.00 1) than the inhibition of the response to the nonspecific mitogen. This dose-titration experiment further confirms the preferential inhibition ofthe antigenspecific response by BBG. The reproducibility of the above findings was confirmed in a series of five separate experiments in which the effect of BBG (100 nmol LBSA/ml) on the proliferative response to the same two stimulants was tested. The mean inhibition of the response to PHA (32±2%) was significantly (P < 0.001) less than the mean inhibition of the antigen-induced response (84±10%). The marked inhibition of antigen-specific lymphoproliferative responses by BBG was not merely the result of a change in the kinetics ofthe proliferative response. This is demonstrated by the results shown in Table II , in which the effect of culture duration on the inhibitory effect of BBG was studied. BBG (100 nmol LBSA/ml) were added just before the stimulating antigen, tetanus toxoid. The cultures were harvested 3-8 d later. Significant inhibition (P < 0.02) by BBG was seen at each time point. In fact, while 3H-thymidine uptake by control cultures exhibited a 6.5-fold increase from day 3 to day 6, (Fig. 2 ). An increasing degree of inhibition, not abrogated by simple washing of the cells, was observed as the duration of preexposure was lengthened (Fig. 2) . Thus, even when followed by washing, 48-or 72-h preincubation of PBMC in BBG resulted in 76±10 and 73±17% inhibition, respectively, of subsequently tested 3H-thymidine uptake, compared to that of cultures that were preincubated in control complete medium (P = 0.025). These results indicated that 48-72-h preincubation of separated PBMC subpopulations in BBG should allow determination of which PBMC subpopulation(s) was affected by preincubation in BBG, thereby inducing a state of unresponsiveness of PBMC to subsequent antigenic stimulation. (Fig. 3) , the effectiveness of the cell separation procedures and the proliferative response of these two subpopulations when combined after separate preincubation for 72 h in control medium were tested. Neither subpopulation alone yielded >1% of the proliferative response of unseparated cells (P < 0.001). In contrast, the recombined subpopulations exhibited a response not significantly different from that of the unseparated PBMC (P > 0.9).
Having confirmed the effectiveness of the separation procedure and the functional integrity of the recombined subpopulations, we next studied the effect of separate preincubation of the adherent and nonadherent subpopulations in BBG (100 nmol LBSA/ml). Each subpopulation was preincubated in BBG or in control medium for 4-72 h and then washed. The subpopulations were then recombined and the proliferative response to a soluble specific antigen (SKSD or tetanus toxoid) measured. The findings of these five experiments (Fig. 4) were: (a) As expected from the results shown in Fig. 2 of PBMC to BBG is the result of an effect on the adherent monocyte (and its functional capability as an accessory cell), and not the result of interference with the ability of the nonadherent cell subpopulation to proliferate in response to effective antigenic stimulation.
The delineation of a selective effect of BBG on adherent monocyte accessory function raises several additional questions that were addressed experimentally. These wells was 93±6% of the number that remained in the control wells (P > 0.4). Therefore, there is no evidence suggesting that a direct cytotoxic effect or loss of adherent monocytes could explain the BBG-induced inhibition of adherent monocyte accessory function.
Since gangliosides adhere to plastic surfaces (15), another possible explanation for inhibition could have been that adsorption of BBG to the plastic wells in which the adherent cells were precultured could have resulted in inhibition of the washed cells, which were subsequently cultured in the same wells to assess lymphoproliferation. This would be highly unlikely, since, at the ganglioside concentration used, <1% of the BBG (or 1 nmol LBSA/ml) would be expected to adhere to the plastic (15) . We nevertheless tested whether functionally active quantities of BBG remained adsorbed to the plastic surface by adding control PBMC to wells in which gangliosides (100 nmol LBSA/ml complete medium) had been allowed to adsorb for 72 h, after which the wells were rinsed. There was no inhibition of the proliferative response to SKSD of PBMC cultured in BBG-pretreated wells, compared to control wells (30.6±3.9 vs. 27.2±1.2 X 103 cpm, respectively). In contrast, the original concentration of BBG (100 nmol LBSA/ml) caused 78% inhibition of control PBMC responses (6.0±0.6 X 103 cpm/culture). Thus, adsorbed BBG were not responsible for the inhibitory effects that resulted from the preincubation of the adherent cell subpopulation in BBG.
To determine whether mode of presentation of BBG (i.e., free or liposome incorporated) might be a factor in causing selective inhibition of adherent monocyte accessory function, BBG were incorporated in cholesterol/lecithin liposomes (as described in Methods). Preincubation of adherent monocytes in liposome-incorporated BBG (50 or 100 nmol LBSA/ml complete medium) for 72 h resulted in 95 and 99% inhibition, respectively, of the subsequent proliferative responses of control nonadherent cells to tetanus toxoid, compared with the response observed when adherent cells were preincubated in either control complete medium or complete medium containing cholesterol/lecithin liposomes (P < 0.001). Thus, both BBG added in solution and BBG incorporated into liposomes markedly inhibit adherent monocyte accessory function.
Reversibility of BBG-induced inhibition of adherent accessory cell function. To determine whether the selective effect (i.e., on the adherent cell subpopulation) of preincubation of PBMC in BBG was the result of induction of suppressor activity in this subpopulation or the result of direct interference of BBG with the accessory functional capability ofthe adherent monocyte, we tested the ability of untreated monocytes to overcome the inhibitory effect caused by the preincubation of the adherent cell subpopulation in BBG. In this experiment, adherent cells were preincubated with BBG (100 nmol LBSA/ ml) for 72 h, washed, and then combined with either control nonadherent cells or control PBMC (the latter containing both 2078 5. Ladisch, L. Ulsh, B. Gillard, and C. Wong I control adherent and control nonadherent subpopulations). Fig. 5 shows that the addition of control total PBMC to BBGpretreated adherent cells completely abrogated the significant inhibition (P < 0.001) observed when only control nonadherent cells were added to BBG-pretreated adherent cells. This effect of the addition of untreated monocytes strongly suggests that BBG directly inhibit the accessory function of adherent monocytes rather than induce suppressor activity in the adherent cell subpopulation.
It was therefore of interest to determine whether the noncytotoxic, direct, inhibitory effect of BBG represented a permanent (i.e., irreversible) effect on adherent monocyte accessory function, or whether prolonged further incubation of BBG-pretreated adherent cells in control medium could restore their functional capability. To test these possibilities, adherent cells were exposed to BBG (100 nmol LBSA/ml) for 72 h and then washed. The BBG-pretreated adherent cells were then either immediately cultured with nonadherent cells and tetanus toxoid, or incubated for an additional 72 h in control medium, washed again, and then cultured with nonadherent cells and tetanus toxoid. To eliminate possible remaining monocytes that were not removed by the adherence procedure, the nonadherent cell subpopulation was further purified by E-rosetting and filtration through a Sephadex G-10 column to yield a T cell population that was virtually devoid of contaminating monocytes (16) . As shown in Fig. 6 (solid bars), preincubation of adherent cells in control medium for 72-144 h resulted in 3H-thymidine uptake of 6-9 X 103 cpm/culture, when control T cells were added at the end of these preincubation times. Both observed, which demonstrated that inhibition of the accessory functional capability of adherent monotypes by BBG is ultimately reversible. These findings also provide supporting evidence for the previously stated conclusion that exposure of adherent monocytes to BBG did not result in the actual loss (e.g., by detachment) of certain monocytes that were critical for the accessory function. Finally, the addition of BBG incorporated into liposomes (Fig. 6 , stippled bars) gave statistically similar results (P > 0.1) to those that were obtained when BBG were added in solution.
Taken together, the findings of these studies support the conclusion that BBG directly interfere with the accessory functional capability of adherent monocytes, and do so in a noncytotoxic and reversible manner.
Discussion
Gangliosides are potent inhibitors ofthe proliferative responses of PBMC to antigenic stimulation in vitro (4) (5) (6) (7) (8) . Accumulating evidence of abnormalities in circulating gangliosides in certain disease states associated with immunodeficiency, such as cancer (1, 17, 18) , suggests that inhibition of lymphoproliferation by gangliosides may be of in vivo relevance. This possibility is strengthened by recent findings that the effector cell generated by an intact lymphoproliferative response, the cytotoxic T cell, is capable of eliminating tumor cells in vivo (19, 20) . findings underscore the importance of studying immunosuppressive factors, such as gangliosides, which occur in vivo and are present in the local environment (e.g., of tumor) where they might affect immune responses, and of elucidating the mechanisms by which they inhibit lymphoproliferative responses. Previous studies identified two characteristics of inhibition of lymphoproliferative responses by gangliosides. First, gangliosides present during the culture period directly interfere with the proliferation of mitogen-activated lymphocytes (6) , possibly by inhibiting lymphocyte Ca++ influx normally associated with lymphocyte activation (21). Second, preincubation in gangliosides impairs the responsiveness of human PBMC to subsequent activation by stimulants of lymphoproliferation (7) . The present studies were addressed to the identification of the immunologic mechanism resulting in this state of impaired responsiveness. This question was approached by determining which of the subpopulation(s) of PBMC was affected by preincubation with gangliosides.
Our results demonstrate that BBG inhibit accessory function of the adherent (monocyte-enriched) subpopulation, which is critical to antigen-induced lymphoproliferative responses. The inhibition is mediated by a direct effect on the functional capability of these cells rather than by the induction of suppressor activity. Also, this state of temporary unresponsiveness, or paralysis, of adherent monocyte accessory function induced by BBG was independent of the mode of presentation of BBG. Although it has previously been suggested that gangliosides added in solution may interact differently with PBMC than do gangliosides incorporated in liposomes (7), our findings indicate that, aside from slight quantitative differences in inhibition associated with the mode of presentation, the mode of presentation does not in itself alter the immunologic mechanism by which these gangliosides act when preincubated with PBMC-that is, abrogation of adherent monocyte accessory function.
Why they provide one explanation for the high degree of inhibition of soluble specific antigen-induced (vs. nonspecific mitogeninduced) lymphoproliferative responses by gangliosides. The initiation of specific antigen-induced lymphoproliferative responses is critically dependent upon intact adherent monocyte accessory function (9, 10) . This knowledge would predict that modulation by gangliosides of the function of both adherent monocytes (present study) and of lymphocytes (6) might result in very substantial inhibition of antigen-specific responses, as we in fact observed. Since specific antigens are the relevant stimulants of the cellular immune response in vivo, the marked inhibition of antigen-specific lymphoproliferative responses by gangliosides in vitro suggests that these glycolipids may be very potent, biologically relevant, immunoregulatory molecules in vivo.
